Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
about
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.The intrinsically disordered E-domains regulate the IGF-1 prohormones stability, subcellular localisation and secretion.New Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast CancerMolecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers
P2860
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@en
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@nl
type
label
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@en
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@nl
prefLabel
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@en
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
@nl
P2860
P50
P1433
P1476
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor
@en
P2093
Luciana Vallorani
Vilberto Stocchi
P2860
P2888
P304
P356
10.1007/S13402-015-0263-3
P50
P577
2015-12-23T00:00:00Z